The management of stage III NSCLC is controversial and rapidly evolving, to the point that practitioners have difficulty processing and understanding the fast moving changes in the standard of care and communications among multidisciplinary teams is challenging given the uneven knowledge levels.

It is imperative that lung cancer health care professionals remain current in the state-of-the-art management and techniques. Attendees need to determine when and how the latest clinical trial findings will affect their day-to-day practice, and thus be able to narrow competency gaps in management of this large proportion of NSCLC patients.

This will be a series of lectures by experts on complex areas in the current management of stage III NSCLC. Panelists will provide foundational information and then will dialogue as a group under the direction of the moderator to clarify areas of uncertainty and controversy. Panelists will also answer questions from the participants in the audience to further explain difficult clinical challenges in stage III NSCLC.